Loading page…
Consolidated figures · ₹ crore
| ₹ Cr | Mar 2026 |
|---|---|
| Revenue | 89 |
| COGS | 26 |
| Gross profit | 62 |
| 54 | |
| 8 | |
| OPM % | 9.4% |
| Depreciation | 5 |
| Interest | 0 |
| 2 | |
| Profit before tax | 5 |
| Tax | 1 |
| Tax % | 27.4% |
| PAT | 3 |
| PAT margin % | 3.8% |
| EPS (₹) | 2 |
| ₹ Cr | Mar 2026 |
|---|---|
| Equity capital | — |
| Reserves | — |
| Borrowings | — |
| 73 | |
| Total equity & liabilities | 73 |
| Fixed assets | 34 |
| CWIP | — |
| Investments | 12 |
| 27 | |
| Total assets | 73 |
| ₹ Cr | Mar 2026 |
|---|---|
| 2 | |
| -0 | |
| 0 | |
| Net cash flow | 2 |
| Free cash flow | -5 |
| CFO / Operating profit % | 26.6% |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Income from IPD Services | 43.3 | 32.71 | 32.47 | 2.61 | 29.86 | 109.54 |
| Income from OPD Services | 25.19 | 21.19 |
| 4.5 |
| 1.19 |
| 3.31 |
| 640.18 |
| Income from sale of medicines from pharmacy | 20.36 | 4.62 | 6.6 | 6.87 | — | — |
| Add: Others | 0.8 | 1.55 | 29.1 | 5.14 | 23.96 | 6.47 |
| Add: Profit on Sale of Investment | 0.44 | 0 | 0 | 0 | — | — |
| Add: Dialysis machine Rental charges | 0.18 | 0 | 0 | 0 | — | — |
| Add: Interest Income | 0.11 | 0 | 0 | 0 | — | — |
| Add: Technician Charges for Dialysis | 0.01 | 0 | 0 | 0 | — | — |
| Less: Discount | -0.12 | 0 | 0 | 0 | — | — |
₹ crore by fiscal year